Version 2.0 of President Barack Obama’s health insurance overhaul represents another chance to win over a skeptical public. But more than possible computer woes lurk as HealthCare.gov’s second open enrollment season begins Nov. 15.
On Obamacare, the new Republican-controlled Congress should “leave the façade of the building and then demolish the inside of it,” according to one GOP leader. If Republicans take that approach, here are four things that could change in the next two years.
AgriNovus, the newest initiative of the Central Indiana Corporate Partnership, wants to help Hooosier ag companies play a leading role in figuring out to feed the world’s fast-growing population.
Retail clinics and urgent care centers are proliferating. That could expand the market for health care. But if consumers decide instead to make strip malls the front door to their health care—rather than traditional physician offices—the hospital systems could see their market shares waning.
WellPoint’s stock has benefited the most among major insurers since the 2013 launch of the Obamacare exchanges, along with tax subsidies to buy insurance.
Covance manages clinical trials for drugmakers including locally-based Eli Lilly and Co. It employs about 1,500 workers in Indianapolis and Greenfield.
While foes of the Affordable Care Act warned of double-digit rate increases, the costs of premiums seen so far is more modest for the new year.
The insurer will not let customers who renewed their pre-Obamacare plans late in 2013 do so again this year. But switching to Obamacare-compliant plans could cause some premiums to spike and provider choice to dwindle.
Obamacare's community rating rules would give 25-percent-off coupons to boomers while sticking millennials with a 75-percent surcharge, according to recent data from employer health plans.
Eli Lilly and Co. would be a logical acquirer for the maker of a drug that could treat agitation in Alzheimer’s patients.
Health insurers such as WellPoint Inc. entered last fall cautious about a major coverage expansion initiated by the health care overhaul, but are finding the challenges more manageable than expected.
In the decade after the founding of the BioCrossroads initiative, money spent on life sciences research and companies more than doubled, according to a report released Thursday by the Indianapolis-based life sciences business development group.
Slowing domestic growth pushes executives to brighter markets.
Enrollment in WellPoint’s health plans increased by 259,000 members in the third quarter. Growth came in WellPoint’s employer and Medicaid plans, while its individual health plans declined by 108,000.
Dr. Eric Jones of Pendleton was arrested Tuesday at his general family practice about 25 miles northeast of Indianapolis.
Judge Rebecca Doherty in Lafayette, Louisiana, said the jury’s decision to order Takeda to pay $6 billion and Lilly $3 billion was excessive and should be reduced to a total of $36.8 million.
Seals Ambulance, with 325 workers and nearly $13 million in revenue, will be acquired by Priority Ambulance, but keep its local leadership and name.
Lilly CEO John Lechleiter kicked off the company’s quarterly conference call with investors and analysts by declaring an end to the “unprecedented challenge” that Lilly lived through the past four years.
Some of Indiana's mayors and law enforcement officials are urging lawmakers to combat the state's methamphetamine scourge by making some cold medications available only by prescription.
Eli Lilly and Co. and Zymeworks said Wednesday that they are expanding a cancer drug development partnership.
